Close

Informatica Blogs

Close

Informatica on Facebook

Close

Informatica on Twitter

Aventis

To achieve faster ROI on its research and bring new drugs to market sooner, the company needed to accelerate its decision-making capabilities.

A German pharmaceutical company with 75,000 employees, Aventis has invested nearly EUR 3 billion in research and development. To achieve faster ROI on its research and bring new drugs to market sooner, the company needed to accelerate its decision-making capabilities.

Challenges

  • Automate the gathering of research data from 11 discrete systems
  • Standardize research data for faster reporting
  • Speed distribution of reports and metrics to decision-makers
In our sector, it is imperative to be the first to obtain competitive advantage and an ROI on our research studies. Adding to this is the growing competition, and one can easily understand that time is represented even more in financial terms. In this harsh environment, Informatica became a valuable ally for daily reporting and thus guarantees our teams the optimum responsiveness and effectiveness.
— Alain Afios
Head of Data Processing, R&D
Aventis
Read Success Story PDF

Results

  • Improved early detection of R&D issues
  • Significantly decreased time-to-market
  • Ensured researchers have timely access to accurate, up-to-date data

Technologies Used

  • Accesses, integrates, and delivers any and all data quickly and cost-effectively, without hand coding.

Browse customers
by industry, solution,
or product
Read More Now
green promo marketplace 240x125